Kaley N, Liveris Z, Moore M, Reidl C, Wawrzak Z, Becker D
Protein Sci. 2024; 34(1):e70014.
PMID: 39720892
PMC: 11669113.
DOI: 10.1002/pro.70014.
Homolya L, Mathomes R, Varga L, Docsa T, Juhasz L, Hayes J
Int J Mol Sci. 2024; 25(9).
PMID: 38731811
PMC: 11083775.
DOI: 10.3390/ijms25094591.
Reina E, Franco L, Carneiro T, Barreiro E, Lima L
RSC Adv. 2024; 14(10):6617-6626.
PMID: 38390500
PMC: 10882265.
DOI: 10.1039/d4ra00450g.
Akwata D, Kempen A, Lamptey J, Dayal N, Brauer N, Sintim H
RSC Med Chem. 2024; 15(1):178-192.
PMID: 38283221
PMC: 10809330.
DOI: 10.1039/d3md00415e.
Darnotuk E, Siniavin A, Shastina N, Luyksaar S, Inshakova A, Bondareva N
Pharmaceuticals (Basel). 2024; 17(1).
PMID: 38256869
PMC: 10821229.
DOI: 10.3390/ph17010035.
Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents.
Altintop M, Canturk Z, Ozdemir A
ACS Omega. 2023; 8(45):42867-42877.
PMID: 38024728
PMC: 10652261.
DOI: 10.1021/acsomega.3c05860.
Strategies in the Design and Development of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs).
Vanangamudi M, Palaniappan S, Kathiravan M, Namasivayam V
Viruses. 2023; 15(10).
PMID: 37896769
PMC: 10610861.
DOI: 10.3390/v15101992.
Novel hybrid motifs of 4-nitroimidazole-piperazinyl tagged 1,2,3-triazoles: Synthesis, crystal structure, anticancer evaluations, and molecular docking study.
Saber S, Al-Qawasmeh R, Abu-Qatouseh L, Shtaiwi A, Khanfar M, Al-Soud Y
Heliyon. 2023; 9(9):e19327.
PMID: 37681149
PMC: 10480608.
DOI: 10.1016/j.heliyon.2023.e19327.
The Magic Methyl and Its Tricks in Drug Discovery and Development.
Pinheiro P, Franco L, Fraga C
Pharmaceuticals (Basel). 2023; 16(8).
PMID: 37631072
PMC: 10457765.
DOI: 10.3390/ph16081157.
Design, Synthesis and Phenotypic Profiling of Simplified Gedatolisib Analogues.
Costa C, Aparecida-Silva C, Gamba L, de Melo T, Barbosa G, Moraes Junior M
Pharmaceuticals (Basel). 2023; 16(2).
PMID: 37259357
PMC: 9964390.
DOI: 10.3390/ph16020209.
Production of a Monoclonal Antibody for the Detection of Forchlorfenuron: Application in an Indirect Enzyme-Linked Immunosorbent Assay and Immunochromatographic Strip.
Lei X, Abd El-Aty A, Xu L, Zhao J, Li J, Gao S
Biosensors (Basel). 2023; 13(2).
PMID: 36832005
PMC: 9954037.
DOI: 10.3390/bios13020239.
Imidazole: Synthesis, Functionalization and Physicochemical Properties of a Privileged Structure in Medicinal Chemistry.
Tolomeu H, Fraga C
Molecules. 2023; 28(2).
PMID: 36677894
PMC: 9865940.
DOI: 10.3390/molecules28020838.
In Vitro and In Silico Biological Studies of 4-Phenyl-2-quinolone (4-PQ) Derivatives as Anticancer Agents.
Chen Y, Lawal B, Huang L, Kuo S, Sumitra M, Mokgautsi N
Molecules. 2023; 28(2).
PMID: 36677621
PMC: 9861105.
DOI: 10.3390/molecules28020555.
Chemistry and Biological Activities of Naturally Occurring and Structurally Modified Podophyllotoxins.
Jin L, Song Z, Cai F, Ruan L, Jiang R
Molecules. 2023; 28(1).
PMID: 36615496
PMC: 9822336.
DOI: 10.3390/molecules28010302.
A Novel Protocol for the Synthesis of 1,2,4-Oxadiazoles Active against Trypanosomatids and Drug-Resistant Leukemia Cell Lines.
Pitasse-Santos P, Salustiano E, Pena R, Augusto Chaves O, Fonseca L, Da Costa K
Trop Med Infect Dis. 2022; 7(12).
PMID: 36548658
PMC: 9787607.
DOI: 10.3390/tropicalmed7120403.
Bio-Inspired Deaminative Hydroxylation of Aminoheterocycles and Electron-Deficient Anilines.
Ghiazza C, Wagner L, Fernandez S, Leutzsch M, Cornella J
Angew Chem Int Ed Engl. 2022; 62(2):e202212219.
PMID: 36479796
PMC: 10107619.
DOI: 10.1002/anie.202212219.
Methyl Effect on the Metabolism, Chemical Stability, and Permeability Profile of Bioactive -Sulfonylhydrazones.
Guedes J, Carneiro T, Pinheiro P, Fraga C, Sant Anna C, Barreiro E
ACS Omega. 2022; 7(43):38752-38765.
PMID: 36340078
PMC: 9631887.
DOI: 10.1021/acsomega.2c04368.
Synthesis and Evaluation of Antiproliferative Activity, Topoisomerase IIα Inhibition, DNA Binding and Non-Clinical Toxicity of New Acridine-Thiosemicarbazone Derivatives.
Sousa G, de Almeida M, Locio L, Dos Santos V, Bezerra D, Silva V
Pharmaceuticals (Basel). 2022; 15(9).
PMID: 36145320
PMC: 9506480.
DOI: 10.3390/ph15091098.
Contemporary medicinal chemistry strategies for the discovery and optimization of influenza inhibitors targeting vRNP constituent proteins.
Hou L, Zhang Y, Ju H, Cherukupalli S, Jia R, Zhang J
Acta Pharm Sin B. 2022; 12(4):1805-1824.
PMID: 35847499
PMC: 9279641.
DOI: 10.1016/j.apsb.2021.11.018.
Pre-clinical evaluation of LASSBio-1491: From in vitro pharmacokinetic study to in vivo leishmanicidal activity.
de Queiroz A, Barbosa G, de Oliveira V, de Mattos Alves H, Alves M, Carregaro V
PLoS One. 2022; 17(6):e0269447.
PMID: 35666748
PMC: 9170106.
DOI: 10.1371/journal.pone.0269447.
